Type II monocytes modulate T cell–mediated central nervous system autoimmune disease

Cited by (441)

Items 201–300 of 441

1. Sex differences in monocytes and TLR4 associated immune responses; implications for systemic lupus erythematosus (SLE)
   Wei Jiang, Gary S. Gilkeson · 2014 · Journal of Immunotherapy Applications
2. Current and Future Therapies Targeting the Immune System in Multiple Sclerosis
   Verena Loleit, Viola Biberacher, Bernhard Hemmer · 2014 · Current Pharmaceutical Biotechnology
3. Lenalidomide regulates CNS autoimmunity by promoting M2 macrophages polarization
   Qinjie Weng, Jiaying Wang, Jiajia Wang, Jing Wang, Fahmida Sattar, Zhikang Zhang, Jiahuan Zheng, Zijie Xu, Mengting Zhao, Xuan Liu et al. · 2018 · Cell Death and Disease
4. Treatment with IL-10 producing B cells in combination with E2 ameliorates EAE severity and decreases CNS inflammation in B cell-deficient mice
   Jun Zhang, Andrew S. Lapato, Sheetal Bodhankar, Arthur A. Vandenbark, Halina Offner · 2015 · Metabolic Brain Disease
5. AMP-Activated Protein Kinase Suppresses Autoimmune Central Nervous System Disease by Regulating M1-Type Macrophage–Th17 Axis
   Ashutosh Kumar Mangalam, Ramandeep Rattan, Hamid Suhail, Jaspreet Singh, Md Nasrul Hoda, Mandar Deshpande, Sadanand Fulzele, Aleksandar Đenić, Viji Shridhar, Ashok Kumar et al. · 2016 · The Journal of Immunology
6. Glatiramer Acetate in Treatment of Multiple Sclerosis: A Toolbox of Random Co-Polymers for Targeting Inflammatory Mechanisms of both the Innate and Adaptive Immune System?
   Babak Jalilian, Halldór Bjarki Einarsson, Thomas Vorup‐Jensen · 2012 · International Journal of Molecular Sciences
7. Repetitive Pertussis Toxin Promotes Development of Regulatory T Cells and Prevents Central Nervous System Autoimmune Disease
   Martin S. Weber, Mahdia Benkhoucha, Klaus Lehmann‐Horn, Deetje Hertzenberg, Johann Sellner, Marie‐Laure Santiago‐Raber, Michel Chofflon, Bernhard Hemmer, Scott S. Zamvil, Patrice H. Lalive · 2010 · PLoS ONE
8. Gene expression analysis reveals functional pathways of glatiramer acetate activation
   Shlomo Bakshi, Vered Chalifa Caspi, Inbar Plaschkes, Igor Perevozkin, Michael Gurevich, Riki Schwartz · 2013 · Expert Opinion on Therapeutic Targets
9. Pharmacogenomics strategies to optimize treatments for multiple sclerosis: Insights from clinical research
   Iris Grossman, Volker A. Knappertz, Daphna Laifenfeld, Colin J. Ross, Ben Zeskind, Sarah E. Kolitz, David Ladkani, Liat Hayardeny, Pippa S. Loupe, Ralph Laufer et al. · 2016 · Progress in Neurobiology
10. Glatiramer acetate for the treatment of multiple sclerosis: evidence for a dual anti-inflammatory and neuroprotective role
    Roland Liblau · 2009 · Journal of the Neurological Sciences
11. Recombinant adeno‐associated viral ( rAAV ) vectors mediate efficient gene transduction in cultured neonatal and adult microglia
    Wei Su, John Kang, Bryce L. Sopher, James Gillespie, Macarena S. Aloi, Guy L. Odom, Stephanie Hopkins, Amanda Case, David B. Wang, Jeffrey S. Chamberlain et al. · 2015 · Journal of Neurochemistry
12. Tregs and infections: on the potential value of modifying their function
    Sharvan Sehrawat, Barry T. Rouse · 2011 · Journal of Leukocyte Biology
13. Double Roles of Macrophages in Human Neuroimmune Diseases and Their Animal Models
    Xueli Fan, Hongliang Zhang, Yun Cheng, Xinmei Jiang, Jie Zhu, Tao Jin · 2016 · Mediators of Inflammation
14. Glatiramer Acetate Treatment Directly Targets CD11b+Ly6G− Monocytes and Enhances the Suppression of Autoreactive T cells in Experimental Autoimmune Encephalomyelitis
    Aras Toker, Clare Y. Slaney, B. Thomas Bäckström, J. L. Harper · 2011 · Scandinavian Journal of Immunology
15. Monocytes P2X7 purinergic receptor is modulated by glatiramer acetate in multiple sclerosis
    Mariantonietta Caragnano, Paola Tortorella, Alessandra Bergami, Maddalena Ruggieri, Paolo Livrea, Luigi Maria Specchio, Gianvito Martino, María Trojano, Roberto Furlan, Carlo Avolio · 2012 · Journal of Neuroimmunology
16. Pre-treatment T-cell subsets associate with fingolimod treatment responsiveness in multiple sclerosis
    Mahtab Ghadiri, Ayman Rezk, Rui Li, Ashley Evans, Paul Steven Giacomini, Michael Harry Barnett, Jack Perry Antel, Amit Bar‐Or · 2020 · Scientific Reports
17. RETRACTED: Mechanisms of M2 Macrophage-Derived Exosomal Long Non-coding RNA PVT1 in Regulating Th17 Cell Response in Experimental Autoimmune Encephalomyelitisa
    Lei Wu, Jinjin Xia, Donghui Li, Ying Kang, Wei Yi Fang, Peng Huang · 2020 · Frontiers in Immunology · Retracted
18. A One Year Follow-Up Study of Natural Killer and Dendritic Cells Activities in Multiple Sclerosis Patients Receiving Glatiramer Acetate (GA)
    Rune Alexander Høglund, Trygve Holmøy, Hanne Flinstad Harbo, Azzam A. Maghazachi · 2013 · PLoS ONE
19. Glatiramer acetate triggers PI3Kδ/Akt and MEK/ERK pathways to induce IL-1 receptor antagonist in human monocytes
    Rakel Carpintero, Karim J. Brandt, Lyssia Gruaz, Nicolas Molnarfi, Patrice H. Lalive, Danielle Burger · 2010 · Proceedings of the National Academy of Sciences
20. Overlapping and distinct mechanisms of action of multiple sclerosis therapies
    Jerome J. Graber, Corey A. McGraw, Dorlan J. Kimbrough, Suhayl S. Dhib-Jalbut · 2010 · Clinical Neurology and Neurosurgery
21. The Molecular Mechanisms of Vitamin A Deficiency in Multiple Sclerosis
    Ahmadreza Dorosty Motlagh, Niyaz Mohammadzadeh Honarvar, Mohsen Sedighiyan, Mina Abdolahi · 2016 · Journal of Molecular Neuroscience
22. Dexmedetomidine reduces inflammation in traumatic brain injury by regulating the inflammatory responses of macrophages and splenocytes
    Mengyao Ding, Ying Chen, Hengfei Luan, Xiaobao Zhang, Zhibin Zhao, Yong Wu · 2019 · Experimental and Therapeutic Medicine
23. Anti-IgD antibody attenuates collagen-induced arthritis by selectively depleting mature B-cells and promoting immune tolerance
    Tue Gia Nguyen, Christopher B. Little, Vanessa M. Yenson, Chris Jackson, Sharon A. McCracken, Julia Warning, Veronica A. Stevens, Eileen G. Gallery, Jonathan M Morris · 2010 · Journal of Autoimmunity
24. T-Cell Based Immunotherapy in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis
    Kate O’Brien, Bruno Gran, Abdolmohamad M. Rostami · 2009 · Immunotherapy
25. Neither T-helper type 2 nor Foxp3+regulatory T cells are necessary for therapeutic benefit of atorvastatin in treatment of central nervous system autoimmunity
    Martin S. Weber, Thomas Prod’homme, Sawsan Youssef, Shannon E. Dunn, Lawrence Steinman, Scott S. Zamvil · 2014 · Journal of Neuroinflammation
26. Transplantation of Microglia in the Area of Spinal Cord Injury in an Acute Period Increases Tissue Sparing, but Not Functional Recovery
    Elvira Ruslanovna Akhmetzyanova, Yana Olegovna Mukhamedshina, M. N Zhuravleva, Luisa R. Galieva, Alexander Kostennikov, Ekaterina Evgenevna Garanina, Albert Anatolyevich Rizvanov · 2018 · Frontiers in Cellular Neuroscience
27. Impact of disease-modifying therapy on dendritic cells and exploring their immunotherapeutic potential in multiple sclerosis
    Caiyun Liu, Jie Zhu, Yan Mi, Tao Jin · 2022 · Journal of Neuroinflammation
28. Dendritic cell, monocyte and T cell activation and response to glatiramer acetate in multiple sclerosis
    Finn Thorup Sellebjerg, Dan Hesse, Signe Limborg, H Lund, Helle Bach Søndergaard, Martin Krakauer, Per Soelberg Sørensen · 2012 · Multiple Sclerosis Journal
29. Restoring immune suppression in the multiple sclerosis brain
    Nathalie Koning, Bernard M.J. Uitdehaag, Inge Huitinga, Robert M. Hoek · 2009 · Progress in Neurobiology
30. Neuroantigen-Specific Autoregulatory CD8+ T Cells Inhibit Autoimmune Demyelination through Modulation of Dendritic Cell Function
    Venkatesh Prasanna Kashi, Sterling B. Ortega, Nitin J. Karandikar · 2014 · PLoS ONE
31. Enhanced disease reduction using clozapine, an atypical antipsychotic agent, and glatiramer acetate combination therapy in experimental autoimmune encephalomyelitis
    Laura K Green, Pirooz Zareie, Nikki Templeton, Robert A. Keyzers, Bronwen J. Connor, Anne Camille La Flamme · 2017 · Multiple Sclerosis Journal - Experimental Translational and Clinical
32. A role for Apolipoprotein A-I in the pathogenesis of multiple sclerosis
    Meyers, Lindsay, Groover, Chassidy J., Douglas, Joshua, Lee, Sangmin, Brand, David, Levin, Michael C., Gardner, Lidia A. · 2014 · Journal of Neuroimmunology
33. HLA DR and DQ alleles and haplotypes associated with clinical response to glatiramer acetate in multiple sclerosis
    Suhayl S. Dhib-Jalbut, Reuben Mari Valenzuela, Kouichi Ito, Michael Kaufman, Mary Ann Picone, Steven G. Buyske · 2013 · Multiple Sclerosis and Related Disorders
34. Central Nervous System Barriers Impact Distribution and Expression of iNOS and Arginase-1 in Infiltrating Macrophages During Neuroinflammation
    Ivan, Daniela C., Walthert, Sabrina, Locatelli, Giuseppe · 2021 · Frontiers in Immunology
35. Regulation of the maturation of human monocytes into immunosuppressive macrophages
    Defne Bayık, Debra Tross, Lydia Asrat Haile, Daniela I. Verthelyi, Dennis M. Klinman · 2017 · Blood Advances
36. Increased Pro-Thrombotic Platelet Activity Associated with Thrombin/PAR1-Dependent Pathway Disorder in Patients with Secondary Progressive Multiple Sclerosis
    Angela Dziedzic, Elżbieta Dorota Miller, Michał Bijak, Łukasz Przysło, Joanna Saluk · 2020 · International Journal of Molecular Sciences
37. Evaluating Effects of Glatiramer Acetate Treatment on Amyloid Deposition and Tau Phosphorylation in the 3xTg Mouse Model of Alzheimer’s Disease
    Dawling A. Dionisio-Santos, Berke Karaahmet, Elizabeth K. Belcher, Laura D. Owlett, Lee Trojanczyk, John A. Olschowka, M. Kerry O’Banion · 2021 · Frontiers in Neuroscience
38. Aurora Kinase A Regulates M1 Macrophage Polarization and Plays a Role in Experimental Autoimmune Encephalomyelitis
    Lixia Ding, Haijuan Gu, Xiao‐Ming Gao, Sidong Xiong, Biao Q Zheng · 2014 · Inflammation
39. Accelerated central nervous system autoimmunity in BAFF-receptor-deficient mice
    Susan S. Kim, David P. Richman, Scott S. Zamvil, Mark A Agius · 2011 · Journal of the Neurological Sciences
40. Active immunization with myelin-derived altered peptide ligand reduces mechanical pain hypersensitivity following peripheral nerve injury
    Chamini Jayamali Perera, Samuel S. Duffy, Justin G. Lees, Cristina F. Kim, Barbara Cameron, Vasso Apostolopoulos, Gila Moalem‐Taylor · 2015 · Journal of Neuroinflammation
41. Intrathecal anti‐ CD 20 efficiently depletes meningeal B cells in CNS autoimmunity
    Klaus Lehmann‐Horn, Silke Häusser‐Kinzel, Linda Feldmann, Florentine Radelfahr, Bernhard Hemmer, Sarah Traffehn, Claude C.A. Bernard, Christine Stadelmann, Wolfgang Brück, Martin S. Weber · 2014 · Annals of Clinical and Translational Neurology
42. Neuro-Immune Crosstalk in CNS Diseases
    Martin Kerschensteiner, Edgar Meinl, Reinhard Hohlfeld · 2009 · Results and problems in cell differentiation
43. Dendritic cells as therapeutic targets in neuroinflammation
    Felix Lüssi, Frauke Zipp, Esther Witsch · 2016 · Cellular and Molecular Life Sciences
44. Further understanding of the immunopathology of multiple sclerosis: impact on future treatments
    Vikram V. Bhise, Suhayl S. Dhib-Jalbut · 2016 · Expert Review of Clinical Immunology
45. Metabolic response to glatiramer acetate therapy in multiple sclerosis patients
    Lidia De Riccardis, Alessandra Ferramosca, Antonio Danieli, Giorgio Trianni, Vincenzo Zara, Francesca De Robertis, Michele Maffia · 2016 · BBA Clinical
46. Glatiramer acetate immune modulates B-cell antigen presentation in treatment of MS
    Darius Häusler, Zivar Hajiyeva, Jan Traub, Scott S. Zamvil, Patrice H. Lalive, Wolfgang Brück, Martin S. Weber · 2020 · Neurology Neuroimmunology & Neuroinflammation
47. Preventive and Therapeutic Effects of Adenanthin on Experimental Autoimmune Encephalomyelitis by Inhibiting NF-κB Signaling
    Qian-Qian Yin, Chuanxu Liu, Yingli Wu, Shao-Fang Wu, Yan Wang, Xia Zhang, Xiao-Juan Hu, Jian‐Xin Pu, Ying Lu, Hu-Chen Zhou et al. · 2013 · The Journal of Immunology
48. Trichuris suis induces human non-classical patrolling monocytes via the mannose receptor and PKC: implications for multiple sclerosis
    Gijs Kooij, Rens Braster, Jasper J. Koning, Lisa C. Laan, Sandra J. van Vliet, Tamara Los, Anne Marieke Eveleens, Susanne M. A. van der Pol, Elisabeth Förster‐Waldl, Kaan Boztuǧ et al. · 2015 · Acta Neuropathologica Communications
49. Induction of CD4+CD25+Foxp3+ regulatory T cell response by glatiramer acetate in type 1 diabetes
    Guoliang Cui, Yuebo Zhang, Zhenwei Gong, Jingwu Z. Zhang, Ying Qin Zang · 2009 · Cell Research
50. Untitled work
    2011 · PubMed
51. Biological activity of glatiramer acetate on Treg and anti-inflammatory monocytes persists for more than 10 years in responder multiple sclerosis patients
    Michela Spadaro, Francesca Montarolo, Simona Perga, Serena Martire, Federica Brescia, Simona Malucchi, Antonio Bertolotto · 2017 · Clinical Immunology
52. Immunomodulatory Effect of Pregnancy on Leukocyte Populations in Patients With Multiple Sclerosis: A Comparison of Peripheral Blood and Decidual Placental Tissue
    Michela Spadaro, Serena Martire, Luca Marozio, Daniela Mastromauro, Elena Montanari, Simona Perga, Francesca Montarolo, Federica Brescia, Alessia Balbo, Giovanni Botta et al. · 2019 · Frontiers in Immunology
53. Glatiramer Acetate (Copaxone) Modulates Platelet Activation and Inhibits Thrombin-Induced Calcium Influx: Possible Role of Copaxone in Targeting Platelets during Autoimmune Neuroinflammation
    Sarah C. Starossom, Tatyana Veremeyko, Духинова Марина Сергеевна, Amanda W. Y. Yung, Eugene D. Ponomarev · 2014 · PLoS ONE
54. Androgen depletion increases the efficacy of bone marrow transplantation in ameliorating experimental autoimmune encephalomyelitis
    Adele Barnard, Ann P. Chidgey, Claude C.A. Bernard, Richard L. Boyd · 2008 · Blood
55. Glatiramer acetate biases dendritic cells towards an anti-inflammatory phenotype by modulating OPN, IL-17, and RORγt responses and by increasing IL-10 production in experimental allergic encephalomyelitis
    Sakhina Begum-Haque, Marc Christy, Yan Wang, Eli J. Kasper, Javier Ochoa‐Repáraz, Jacqueline Y. Smith, Azizul Haque, Lloyd H. Kasper · 2012 · Journal of Neuroimmunology
56. Glatiramer Acetate Protects Against Inflammatory Synaptopathy in Experimental Autoimmune Encephalomyelitis
    Antonietta Gentile, Silvia Rossi, Valeria Studer, Caterina Motta, Valentina De Chiara, Alessandra Musella, Helena Sepman, Diego Fresegna, Gabriele Musumeci, Giorgio Grasselli et al. · 2013 · Journal of Neuroimmune Pharmacology
57. Sieving Treatment Biomarkers from Blood Gene-Expression Profiles: A Pharmacogenomic Update on two types of Multiple Sclerosis Therapy
    Robert Hermann Goertsches, Uwe Klaus Zettl, Michael Hecker · 2011 · Pharmacogenomics
58. Glatiramer acetate treatment normalized the monocyte activation profile in MS patients to that of healthy controls
    Delgertsetseg Chuluundorj, Scott A. Harding, David A. Abernethy, Anne Camille La Flamme · 2016 · Immunology and Cell Biology
59. Multiple Sclerosis Treatments Affect Monocyte-Derived Microvesicle Production
    Maria Blonda, Antonella Amoruso, Roberta Grasso, Valeria Di Francescantonio, Carlo Avolio · 2017 · Frontiers in Neurology
60. Interleukin-10 and Interleukin-12 Modulation in Patients with Relapsing-Remitting Multiple Sclerosis on Therapy with Interferon-beta 1a: Differences in Responders and Non Responders
    Pietro Biagio Carrieri, Paolo Ladogana, Gaetano Di Spigna, Maria Fulvia de Leva, Maria Petracca, Silvana Montella, Luigi Buonavolontà, Ciro Florio, Loredana Postiglione · 2008 · Immunopharmacology and Immunotoxicology
61. Regulatory Properties of Copolymer I in Th17 Differentiation by Altering STAT3 Phosphorylation
    Chunhua Chen, Xuebin Liu, Bing Wan, Jingwu Z. Zhang · 2009 · The Journal of Immunology
62. New findings and old controversies in the research of multiple sclerosis and its model experimental autoimmune encephalomyelitis
    Rina Aharoni · 2013 · Expert Review of Clinical Immunology
63. Glatiramer acetate and the glatiramoid class of immunomodulator drugs in multiple sclerosis: an update
    Kenneth P. Johnson · 2010 · Expert Opinion on Drug Metabolism & Toxicology
64. Functional effects of the antigen glatiramer acetate are complex and tightly associated with its composition
    Tal H. Hasson, Sarah E. Kolitz, Fadi Towfic, Daphna Laifenfeld, Shlomo Bakshi, Olga Beriozkin, Maya Shacham-Abramson, Bracha Timan, Kevin D. Fowler, Tal Birnberg et al. · 2015 · Journal of Neuroimmunology
65. Modulation of innate immunity by copolymer‐1 leads to neuroprotection in murine HIV‐1 encephalitis
    Santhi Gorantla, Jianuo Liu, Tong Wang, Adelina Holguin, Hannah Sneller, Huanyu Dou, Jonathan Kipnis, Larisa Y. Poluektova, Howard Eliot Gendelman · 2007 · Glia
66. Antigen-Specific Therapy of Multiple Sclerosis: The Long-Sought Magic Bullet
    Lawrence Steinman · 2007 · Neurotherapeutics
67. Endostatin gene therapy inhibits intratumoral macrophage M2 polarization
    Karen Foguer, Marina de Souza Braga, Jean Pierre Schatzmann Peron, Karina Ramalho Bortoluci, Maria Helena Bellini · 2016 · Biomedicine & Pharmacotherapy
68. Glatiramer Acetate Enhances Myeloid-Derived Suppressor Cell Function via Recognition of Paired Ig-like Receptor B
    William van der Touw, Kyeongah Kang, Yi Luan, Ge Ma, Sunny Mai, Lihui Qin, Guanglin Bian, Ruihua Zhang, Sathish Kumar Mungamuri, Hong‐Ming Hu et al. · 2018 · The Journal of Immunology
69. Selective Immunomodulatory and Neuroprotective Effects of a NOD2 Receptor Agonist on Mouse Models of Multiple Sclerosis
    Adham Fani Maleki, Giulia Cisbani, Nataly Laflamme, Paul Préfontaine, Marie-Michèle Plante, Joanie Baillargeon, Manu Rangachari, Jean Gosselin, Serge Rivest · 2021 · Neurotherapeutics
70. Combination treatment of Glatiramer Acetate and Minocycline affects phenotype expression of blood monocyte-derived dendritic cells in Multiple Sclerosis patients
    Maddalena Ruggieri, Carmela Pica, Anna Lia, Giovanni Bosco Zimatore, Mattea Modesto, Emilia Di Liddo, Luigi Maria Specchio, Paolo Livrea, María Trojano, Carlo Avolio · 2008 · Journal of Neuroimmunology
71. Developmental maturation of innate immune cell function correlates with susceptibility to central nervous system autoimmunity
    Deetje Hertzenberg, Klaus Lehmann‐Horn, Silke Häusser‐Kinzel, Veronika Husterer, Petra D. Cravens, Bernd C. Kieseier, Bernhard Hemmer, Wolfgang Brück, Scott S. Zamvil, Olaf Stüve et al. · 2013 · European Journal of Immunology
72. Neuroprotective Potential of Dendritic Cells and Sirtuins in Multiple Sclerosis
    Francesco Piacente, Marta Bottero, Andrea Benzi, Tiziana Vigo, Antonio Uccelli, Santina Bruzzone, Giovanni Battista Ferrara · 2022 · International Journal of Molecular Sciences
73. 12-months prospective Pentraxin-3 and metabolomic evaluation in multiple sclerosis patients treated with glatiramer acetate
    Elisabetta Signoriello, Patrizia Iardino, Sara Casertano, D. De Lucia, Alessia Pucciarelli, Gianfranco Puoti, Emilio Chiosi, Giacomo Lus · 2020 · Journal of Neuroimmunology
74. Managing Risks with Immune Therapies in Multiple Sclerosis
    Moritz Förster, Patrick Küry, Orhan Aktaş, Clemens Warnke, Joachim B. Havla, Reinhard Hohlfeld, Jan Mareš, Hans‐Peter Hartung, David Kremer · 2019 · Drug Safety
75. Cholesterol Modification of p40-Specific Small Interfering RNA Enables Therapeutic Targeting of Dendritic Cells
    Jürgen Brück, Steve Pascolo, Kerstin Fuchs, Christina Kellerer, Ivana Glocova, Julia Geisel, Katja Dengler, Amir Sadegh Yazdi, Martin Röcken, Kamran Ghoreschi · 2015 · The Journal of Immunology
76. Pneumocystis infection alters the activation state of pulmonary macrophages
    Jessica M. Deckman, Cathryn J. Kurkjian, Joseph P. McGillis, Theodore James Cory, Susan E. Birket, Linda M. Schutzman, Brian S. Murphy, Beth A. Garvy, David J. Feola · 2016 · Immunobiology
77. Central nervous system effects of current and emerging multiple sclerosis-directed immuno-therapies
    Jack Perry Antel, Véronique E. Miron · 2008 · Clinical Neurology and Neurosurgery
78. Macrophage-Associated Disorders: Pathophysiology, Treatment Challenges, and Possible Solutions
    Dr Krishna Yadav, Madhulika Pradhan, Deependra Singh, Manju Rawat Singh · 2022 · Springer eBooks
79. Monocyte polarization: the relationship of genome-wide changes in H4 acetylation with polarization
    Z Zhang, Li Song, Kelly Maurer, Asen Bagashev, Kathleen E. Sullivan · 2011 · Genes and Immunity
80. Myelin ingestion alters macrophage antigen-presenting function in vitro and in vivo
    Marloes van Zwam, Janneke N. Samsom, Edward E. S. Nieuwenhuis, Marie‐José Melief, Annet F. Wierenga‐Wolf, Esme Dijke, Simone Talens, Marjan van Meurs, Jane S.A. Voerman, Leonie A. Boven et al. · 2011 · Journal of Leukocyte Biology
81. The heritage of glatiramer acetate and its use in multiple sclerosis
    Gıancarlo Comı, Maria Pia Amato, Antonio Bertolotto, Diego Centonze, Nicola De Stefano, Cinthia Farina, Paolo Gallo, Angelo Ghezzi, Luigi Maria Edoardo Grimaldi, Gianluigi Mancardi et al. · 2016 · Multiple Sclerosis and Demyelinating Disorders
82. Increase of Alternatively Activated Antigen Presenting Cells in Active Experimental Autoimmune Encephalomyelitis
    Beatrice Wasser, Gautam Kumar Pramanik, Moritz Hess, Matthias Klein, Felix Luessi, Klaus Dornmair, Tobias Bopp, Frauke Zipp, Esther Witsch · 2016 · Journal of Neuroimmune Pharmacology
83. Glatiramer Acetate Stimulates Regulatory B Cell Functions
    Kahina Amrouche, Jacques‐Olivier Pers, Christophe Jamin · 2019 · The Journal of Immunology
84. Mediation of Protection and Recovery From Experimental Autoimmune Encephalomyelitis by Macrophages Expressing the Human Voltage-Gated Sodium Channel NaV1.5
    Kusha Rahgozar, Erik Wright, Lisette M. Carrithers, Michael D. Carrithers · 2013 · Journal of Neuropathology & Experimental Neurology
85. An urticarial vasculitis case induced by glatiramer acetate
    Demet Çiçek, Başak Kandi, Sevilay Oğuz, Bengü Çobanoğlu, Serpil Bulut, Yunus Saral · 2008 · Journal of Dermatological Treatment
86. Identification of Orch3, a Locus Controlling Dominant Resistance to Autoimmune Orchitis, as Kinesin Family Member 1C
    Roxana del Río, Ryan D. McAllister, Nathan D. Meeker, Emma H. Wall, Jeffrey P. Bond, Vasileios C. Kyttaris, George C. Tsokos, Kenneth S. K. Tung, Cory Teuscher · 2012 · PLoS Genetics
87. Glatiramer acetate treatment negatively regulates type I interferon signaling
    Nicolas Molnarfi, Thomas Prod’homme, Ulf Schulze‐Topphoff, Collin M. Spencer, Martin S. Weber, Juan Carlos Patarroyo, Patrice H. Lalive, Scott S. Zamvil · 2015 · Neurology Neuroimmunology & Neuroinflammation
88. Myeloid-derived suppressor cells and myeloid regulatory cells in cancer and autoimmune disorders
    Prince Amoah Barnie, Pan Zhang, Hongxiang Lv, Dan Wang, Xiaolian Su, Zhaoliang Su, Huaxi Xu · 2016 · Experimental and Therapeutic Medicine
89. Safety and in vivo immune assessment of escalating doses of oral laquinimod in patients with RRMS
    Tjalf Ziemssen, Hayrettin Tumani, Tony Sehr, Katja Thomas, Friedemann Paul, Nils Richter, Emil E. Samara, Ofer Spiegelstein, Ella Sorani, Oren Bar‐Ilan et al. · 2017 · Journal of Neuroinflammation
90. Gene expression studies of a human monocyte cell line identify dissimilarities between differently manufactured glatiramoids
    Sarah E. Kolitz, Tal H. Hasson, Fadi Towfic, Jason M. Funt, Shlomo Bakshi, Kevin D. Fowler, Daphna Laifenfeld, Augusto Grinspan, Maxim N. Artyomov, Tal Birnberg et al. · 2015 · Scientific Reports
91. Restoration of axon conduction and motor deficits by therapeutic treatment with glatiramer acetate
    Spencer M. Moore, Anna J. Khalaj, Rhusheet Patel, JaeHee Yoon, Daniel Ichwan, Liat Hayardeny, Seema Kaushalya Tiwari-Woodruff · 2014 · Journal of Neuroscience Research
92. Glatiramer acetate for treatment of MS: Regulatory B cells join the cast of players
    Luc Van Kaer · 2010 · Experimental Neurology
93. Modulation of immune function occurs within hours of therapy initiation for multiple sclerosis
    Chris L. Ayers, Jason P. Mendoza, Sushmita Sinha, Khrishen Cunnusamy, Benjamin M. Greenberg, Elliot M. Frohman, Nitin J. Karandikar · 2013 · Clinical Immunology
94. Lipid Receptor G2A-Mediated Signal Pathway Plays a Critical Role in Inflammatory Response by Promoting Classical Macrophage Activation
    Qing Li, Chunlei Feng, Lingyun Li, Guiliang Xu, Haijuan Gu, Shiqiang Li, Dali Li, Mingyao Liu, Shuhua Han, Biao Q Zheng · 2021 · The Journal of Immunology
95. Osteopontin depletion in macrophages perturbs proteostasis via regulating UCHL1-UPS axis and mitochondria-mediated apoptosis
    Altan Rentsendorj, Koen Raedschelders, Dieu-Trang S. Fuchs, Julia Sheyn, Vineet Vaibhav, Rebecca A. Porritt, Haoshen Shi, Jargalsaikhan Dagvadorj, Juliana de Freitas Germano, Yosef Koronyo et al. · 2023 · Frontiers in Immunology
96. Phenotypic Screening-Based Identification of 3,4-Disubstituted Piperidine Derivatives as Macrophage M2 Polarization Modulators: An Opportunity for Treating Multiple Sclerosis
    Qinjie Weng, Jinxin Che, Zhikang Zhang, Jiahuan Zheng, Wenhu Zhan, Sendong Lin, Tian Tian, Jincheng Wang, Renhua Gai, Yongzhou Hu et al. · 2019 · Journal of Medicinal Chemistry
97. A cell type-specific transcriptomic approach to map B cell and monocyte type I interferon-linked pathogenic signatures in Multiple Sclerosis
    Martina Severa, Fabiana Rizzo, Sundararajan Srinivasan, Marco Di Dario, Elena Giacomini, Maria Chiara Buscarinu, Melania Cruciani, Marilena Paola Etna, Silvia Sandini, Rosella Mechelli et al. · 2019 · Journal of Autoimmunity
98. Glatiramer acetate increases T- and B -regulatory cells and decreases granulocyte-macrophage colony-stimulating factor (GM-CSF) in an animal model of multiple sclerosis
    Rina Aharoni, Raya Eilam, Nofar Schottlender, Lihi Radomir, Sandra Leistner-Segal, Tali Feferman, Dana Hirsch, Michael Sela, Ruth Arnon · 2020 · Journal of Neuroimmunology
99. Glatiramer acetate treatment effects on gene expression in monocytes of multiple sclerosis patients
    Madhan Thamilarasan, Michael Hecker, Robert Hermann Goertsches, Brigitte Katrin Paap, Ina Schröder, Dirk Koczan, Hans‐Jürgen Thiesen, Uwe Klaus Zettl · 2013 · Journal of Neuroinflammation
100. IL-27: a potential biomarker for responders to glatiramer acetate therapy
     John E. Mindur, Reuben Mari Valenzuela, Sudhir Kumar Yadav, Sridhar Boppana, Suhayl S. Dhib-Jalbut, Kouichi Ito · 2016 · Journal of Neuroimmunology